glp-1 receptor agonists in idiopathic intracranial hypertension glp 1 receptor agonists in
Description
SELECT Trial (NEJM 2023)
Venegas, C
Multiple studies demonstrate that proliferation due to incretin mimetics can lead to duct occlusion, promoting the premature release of pancreatic enzymes, thereby triggering acinar cell death 18,26
c Mammalian GLP-1: 3297.7
They are used to regulate appetite and blood sugar levels
Exenatide extended-release (Bydureon BCise) injectable suspension
